Our co-founder and CMO, Professor Per-Ola Carlsson, is a leading researcher in the field of type 1 diabetes. His cutting-edge research explores the potential of genetically modified, hypoimmune insulin-producing cells from the Islets of Langerhans as a cure for type 1 diabetes. Here is what he has to say about his research:
“We’ve demonstrated that genetically modified islet cells can safely survive and produce insulin in people with type 1 diabetes-without the need for immunosuppression. These early results are a major step in our research for a cure.”
While the search for a cure continues, Professor Carlsson is also dedicated to improving healthcare:
“My long-term goal is to be able to bring a cure for type 1 diabetes but in the meantime, I strive to improve the clinical management of diabetes and daily life for everyone living with diabetes by developing digital solutions that can automate the interpretation of diabetes data.”
Read more about the study here.
Beyond our own services, we also offer White-Label solutions for companies specializing in diabetes technologies, including Continuous Glucose Monitoring (CGM), insulin pumps, and other related devices. By partnering with us, we can shorten time to market, reduce development costs, and provide new features for data analysis.
Number of people living with diabetes globally and per region
(International Diabetes Federation) 2021
